2 recruiting, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Preterm Preeclampsia: new trials by email Literature Review of Preterm Preeclampsia trials Research Report on Preterm Preeclampsia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study None (this is an observational study with no intervention) - GDM, Preterm Preeclampsia | Recruiting | Medicines360 | 5500 | 2026-09-08 | 2026-11-10 | |
| A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months CBP-4888 - sFlt1 Mediated Preterm Preeclampsia, Preeclampsia | Phase 1 | Recruiting | Comanche Biopharma | 60 | 2025-02-26 | 2026-05-18 |
| Efficacy of Sildenafil in Preterm Preeclampsia Sildenafil, Placebo - Preterm Preeclampsia | Phase 2 / Phase 3 | Withdrawn | The University of Texas Health Science Center, Houston | 2016-07-01 | 2018-03-27 |
Pre-Eclampsia (2) · Fetal Growth Retardation (1) · Pregnancy Complications (1) · Toxemia (1)
Female Urogenital Diseases and Pregnancy Complications (2) · Hypertension, Pregnancy-Induced (2) · Urogenital Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Fetal Diseases (1) · Growth Disorders (1) · Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pregnancy Complications (1)
Comanche Biopharma (1) · Medicines360 (1) · The University of Texas Health Science Center, Houston (1)
Australia (1) · United States (1)